CLEAN : UK first country to legally offer three-parent gene therapy

The video discusses the introduction of mitochondrial replacement therapy in the UK, highlighting its potential to help families with serious mitochondrial diseases. It covers the expected impact, regulatory measures, and the UK's balanced approach to innovation and safety. The therapy has been supported by international scientists and approved by the UK Parliament after extensive public dialogue.

What is the primary goal of mitochondrial replacement therapy?

• To cure all genetic diseases

• To allow families with mitochondrial diseases to have healthy children

• To increase the population

• To replace all mitochondria in the human body

Approximately how many families in the UK might benefit from mitochondrial replacement therapy?

• 100 families

• 3000 families

• 5000 families

• 10000 families

What is a key concern when introducing new medical treatments like mitochondrial replacement therapy?

• The number of doctors available

• The speed of implementation

• The uncertainty and need for safety measures

• The cost of the treatment

What measures are emphasized to ensure the safety of mitochondrial replacement therapy?

• Increasing the number of hospitals

• Rules around prenatal testing and patient consent

• Training more doctors

• Reducing the cost of treatment

How did the UK ensure a balanced approach to mitochondrial replacement therapy?

• By ignoring public opinion

• By focusing solely on innovation

• By relying on expert panels and public dialogue

• By quickly passing laws without debate